Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2016

01-02-2016 | Original Article

A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset

Authors: H. Zheng, Q. Chen, Z. Xie, D. Wang, M. Li, X. Zhang, Y. Man, J. Lao, N. Chen, L. Zhou

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2016

Login to get access

Abstract

Cryptococcal meningoencephalitis (CM) may present as an acute, subacute, or chronic infection. It manifests as a chronic process in over 75 % of cases, but, sometimes, it presents with a more acute onset, mostly in HIV-associated patients. Until now, there has been no study performed on the clinical features of HIV-negative CM patients with acute/subacute onset. We collected 106 HIV-negative patients diagnosed with CM in our hospital during a 15-year period, analyzed their epidemiological and clinical features, as well as the outcomes, and explored the independent prognosis factors and the factors related to the survival time among them. We found that impaired consciousness (23.4 % vs. 3.4 %, p = 0.017) was more common in CM patients with acute/subacute onset, while decreased cerebrospinal fluid (CSF) glucose (51.9 % vs. 75.9 %, p = 0.026) was less common. The ratio of CSF glucose/blood glucose [odds ratio (OR) 0.04, 95 % confidence interval (CI) 0.004–0.262, p = 0.02], impaired consciousness (OR 5.09, 95 % CI 1.477–17.522, p = 0.01), and hospitalization length (OR 0.98, 95 % CI 0.977–0.999, p = 0.04) were indicated to be not only independent prognosis factors in HIV-negative CM patients with acute/subacute onset, but also factors significantly related to the survival time. The results of our study demonstrated that the contact history and potential history risk factors would not affect the onset process of HIV-negative CM patients, and the mortality, hospitalization length, and survival time has not been related to the onset process. However, the ratio of CSF glucose/blood glucose, consciousness level, and hospitalization length of the HIV-negative CM patients with acute/subacute onset should be of greater focus in the clinical work.
Literature
1.
go back to reference Zunt JR, Baldwin KJ (2012) Chronic and subacute meningitis. Continuum (Minneap Minn) 18(6 Infectious Disease):1290–1318 Zunt JR, Baldwin KJ (2012) Chronic and subacute meningitis. Continuum (Minneap Minn) 18(6 Infectious Disease):1290–1318
3.
go back to reference Chimalizeni Y, Tickell D, Connell T (2010) Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV? J Trop Pediatr 56(1):4–12CrossRefPubMed Chimalizeni Y, Tickell D, Connell T (2010) Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV? J Trop Pediatr 56(1):4–12CrossRefPubMed
4.
go back to reference Malessa R, Krams M, Hengge U, Weiller C, Reinhardt V, Volbracht L, Rauhut F, Brockmeyer NH (1994) Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clin Investig 72(12):1020–1026CrossRefPubMed Malessa R, Krams M, Hengge U, Weiller C, Reinhardt V, Volbracht L, Rauhut F, Brockmeyer NH (1994) Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clin Investig 72(12):1020–1026CrossRefPubMed
5.
go back to reference Pappas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, Aberg J, Hasbun R, Hsu HH (2004) Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 189(12):2185–2191CrossRefPubMed Pappas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, Aberg J, Hasbun R, Hsu HH (2004) Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 189(12):2185–2191CrossRefPubMed
6.
go back to reference Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 326(2):83–89CrossRefPubMed Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 326(2):83–89CrossRefPubMed
7.
go back to reference Sloan D, Dlamini S, Paul N, Dedicoat M (2008) Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev 4:CD005647PubMed Sloan D, Dlamini S, Paul N, Dedicoat M (2008) Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev 4:CD005647PubMed
8.
go back to reference Witt MD, Lewis RJ, Larsen RA, Milefchik EN, Leal MA, Haubrich RH, Richie JA, Edwards JE Jr, Ghannoum MA (1996) Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 22(2):322–328CrossRefPubMed Witt MD, Lewis RJ, Larsen RA, Milefchik EN, Leal MA, Haubrich RH, Richie JA, Edwards JE Jr, Ghannoum MA (1996) Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 22(2):322–328CrossRefPubMed
9.
go back to reference Bestard J, Siddiqi ZA (2010) Cryptococcal meningoencephalitis in immunocompetent patients: changing trends in Canada. Neurology 74(15):1233–1235CrossRefPubMed Bestard J, Siddiqi ZA (2010) Cryptococcal meningoencephalitis in immunocompetent patients: changing trends in Canada. Neurology 74(15):1233–1235CrossRefPubMed
10.
go back to reference Kwon-Chung K, Bennett JE (1992) Medical mycology. Lea & Febiger, Philadelphia Kwon-Chung K, Bennett JE (1992) Medical mycology. Lea & Febiger, Philadelphia
11.
go back to reference Yuchong C, Fubin C, Jianghan C, Fenglian W, Nan X, Minghui Y, Yalin S, Zhizhong Z (2012) Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia 173(5–6):329–335CrossRefPubMed Yuchong C, Fubin C, Jianghan C, Fenglian W, Nan X, Minghui Y, Yalin S, Zhizhong Z (2012) Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia 173(5–6):329–335CrossRefPubMed
12.
go back to reference Zheng H, Li M, Luo Y, Wang D, Yang J, Chen Q, Lao J, Chen N, Yang M, Wang Q (2015) A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998–2013). BMC Infect Dis 15(1):77PubMedCentralCrossRefPubMed Zheng H, Li M, Luo Y, Wang D, Yang J, Chen Q, Lao J, Chen N, Yang M, Wang Q (2015) A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998–2013). BMC Infect Dis 15(1):77PubMedCentralCrossRefPubMed
13.
go back to reference Chen CH, Sy HN, Lin LJ, Yen HC, Wang SH, Chen WL, Chen YM, Chang YJ (2015) Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan. J Venom Anim Toxins Incl Trop Dis 21:12PubMedCentralCrossRefPubMed Chen CH, Sy HN, Lin LJ, Yen HC, Wang SH, Chen WL, Chen YM, Chang YJ (2015) Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan. J Venom Anim Toxins Incl Trop Dis 21:12PubMedCentralCrossRefPubMed
14.
go back to reference Brizendine KD, Baddley JW, Pappas PG (2013) Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS One 8(3):e60431PubMedCentralCrossRefPubMed Brizendine KD, Baddley JW, Pappas PG (2013) Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS One 8(3):e60431PubMedCentralCrossRefPubMed
15.
go back to reference Darzé C, Lucena R, Gomes I, Melo A (1999) Prognosis factors in cryptococcal meningoencephalitis. Arq Neuropsiquiatr 57(3A):649–652CrossRefPubMed Darzé C, Lucena R, Gomes I, Melo A (1999) Prognosis factors in cryptococcal meningoencephalitis. Arq Neuropsiquiatr 57(3A):649–652CrossRefPubMed
16.
go back to reference Lu CH, Chang WN, Chang HW, Chuang YC (1999) The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 42(4):313–320CrossRefPubMed Lu CH, Chang WN, Chang HW, Chuang YC (1999) The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 42(4):313–320CrossRefPubMed
17.
go back to reference Majumder S, Mandal SK, Bandyopadhyay D (2011) Prognostic markers in AIDS-related cryptococcal meningitis. J Assoc Physicians India 59:152–154PubMed Majumder S, Mandal SK, Bandyopadhyay D (2011) Prognostic markers in AIDS-related cryptococcal meningitis. J Assoc Physicians India 59:152–154PubMed
18.
go back to reference Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, Chau S, Lai R, Cockram CS (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99(3):143–151CrossRefPubMed Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, Chau S, Lai R, Cockram CS (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99(3):143–151CrossRefPubMed
19.
go back to reference Nigam C, Gahlot R, Kumar V, Chakravarty J, Tilak R (2012) Central nervous system cryptococcosis among a cohort of HIV infected patients from a University Hospital of North India. J Clin Diagn Res 6(8):1385–1387PubMedCentralPubMed Nigam C, Gahlot R, Kumar V, Chakravarty J, Tilak R (2012) Central nervous system cryptococcosis among a cohort of HIV infected patients from a University Hospital of North India. J Clin Diagn Res 6(8):1385–1387PubMedCentralPubMed
20.
go back to reference Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM, Lin PC, Ho MW, Wang JH (2012) Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. J Microbiol Immunol Infect 45(4):296–304CrossRefPubMed Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM, Lin PC, Ho MW, Wang JH (2012) Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. J Microbiol Immunol Infect 45(4):296–304CrossRefPubMed
21.
go back to reference Young GB, Ropper AH, Bolton CF (1998) Coma and impaired consciousness: a clinical perspective. McGraw-Hill, New York Young GB, Ropper AH, Bolton CF (1998) Coma and impaired consciousness: a clinical perspective. McGraw-Hill, New York
Metadata
Title
A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset
Authors
H. Zheng
Q. Chen
Z. Xie
D. Wang
M. Li
X. Zhang
Y. Man
J. Lao
N. Chen
L. Zhou
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2545-0

Other articles of this Issue 2/2016

European Journal of Clinical Microbiology & Infectious Diseases 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.